Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma

Long Jiang; Shanshan Jiang; Dongrong Situ; Yongbin Lin; Han Yang; Yuanfang Li; Hao Long; Zhiwei Zhou

doi:10.18632/oncotarget.3283

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma

Long Jiang _, Shanshan Jiang, Dongrong Situ, Yongbin Lin, Han Yang, Yuanfang Li, Hao Long and Zhiwei Zhou

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:9542-9550. https://doi.org/10.18632/oncotarget.3283

Metrics: PDF 2186 views | HTML 2858 views | ?

Abstract

Long Jiang1,2,3,4,*, Shanshan Jiang1,2,3,*, Dongrong Situ1,2,3,*, Yongbin Lin1,2,3, Han Yang1,2,3, Yuanfang Li1,2,3, Hao Long1,2,3, Zhiwei Zhou1,2,3

1Sun Yat-sen University Cancer Center, Guangzhou, China

2Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

3State Key Laboratory of Oncology in South China, Guangzhou, China

4University of California, San Francisco, CA, USA

*These authors have contributed equally to this work

Correspondence to:

Zhiwei Zhou, e-mail: [email protected]

Hao Long, e-mail: [email protected]

Keywords: soft tissue sarcoma, metastasis, immunity, prognosis

Received: December 23, 2014 Accepted: February 05, 2015 Published: March 20, 2015

ABSTRACT

Metastatic soft tissue sarcomas (STS) represent enormous challenges to improve the low survival rate, which is almost the same as past 2 decades ago. Prognosis of cancer patients are based not only on tumor-related factors but also on host-related factors, particularly systemic inflammatory response. We evaluated the association among possible risk factors and survival for metastatic STS by reviewed a single-institution nearly 50-year experience. We found that both monocyte ratio and NLR ratio were significant prognostic predictors for OS and PFS of metastatic STS. And patients with monocyte ratio or NLR ratio > 1 should be screened out as candidates for more intensive or aggressive multimodality treatments and more aggressive follow-up. For this reason, this result could serve as a basis for future prospective study.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3283

Publication Alerts

Clinical Research Papers:

Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma

Abstract